Welcoming New Clients and Partners to our DNALabs Family

By Moni Lustig, 
President & Chief Executive Officer

As we near the end of March, I am thrilled to share some exciting updates and news from our team at DNALabs.

Firstly, I am excited to announce the latest updates to our MatchMyMeds Drug Compatibility Test. We have been working tirelessly to continuously add new drugs in order to provide our customers with the most accurate and reliable medication management tool available. MatchMyMeds continues to be a leading solution for those seeking a more personalized approach to medication management and we are pleased to now cover 130 drug compounds. We look forward to hearing your feedback as we continue to work towards expanding our panels.

In addition, we are proud to welcome new partners and clients to our growing network. Our collaborations enable us to further expand our reach and provide our services to even more individuals and organizations. We believe that these partnerships will lead to positive outcomes and further advancements in the field of genetics.

Furthermore, we are thrilled to continue our association with Florida Atlantic University (FAU). As a leading research university, FAU has been instrumental in advancing our understanding of genetics and supporting our efforts to develop innovative solutions. We are particularly proud to be associated with the success of the FAU men's basketball team in March Madness. Their outstanding performance is a testament to the hard work and dedication of the FAU community.

Lastly, I would like to share an exciting investment opportunity for those interested in supporting our mission and becoming part of the DNALabs community. We are seeking funding to accelerate our growth and continue driving advancements in the field of genetics. As we continue to develop new products and services, we believe that now is the perfect time to seek support from those who share our vision and mission.

At DNALabs, we remain committed to our mission of improving lives through genetic research and testing. We are grateful for the continued support of our community and look forward to sharing more updates with you in the months to come.

On behalf of the entire DNALabs team, we would like to thank you for your support and wish you and your families a happy and healthy Passover and Easter to all those who will be celebrating!

Questions for our CEO about investment opportunities? Book a call here.

March into Better Health with DNALabs and Nutrition Month

  By Elana Lustig, 
  Director of Marketing

As we say goodbye to March, we at DNALabs would like to wish you and your families a happy (early) Passover and Easter to all those who celebrate.

March was National Nutrition Month, and we couldn’t think of a better way to celebrate than by sharing our passion for healthy living with you. At DNALabs, we believe that nutrition is the foundation of good health and we’re committed to helping you make informed food choices that will fuel your body and mind.

As we enter the spring months, we’re excited to continue working on a range of new products and services that we think you’ll love. From personalized nutrition plans to advanced pharmacogenomics testing, we’re dedicated to providing you with innovative tools that will help you optimize your health.

   Dr. Aaron Goldman, PhD
  Chief Science Officer

 

I’ve previously written a lot about pharmacogenomics, and how it’s shaping the future of medicine by tailoring drug prescriptions to an individual’s genetic makeup. Today, let’s dive deeper into the world of drug metabolism and explore how drug-drug interaction data can give us insights into potential gene-drug interactions. For example, understanding the effects of medications that act as inhibitors can help us comprehend how poor metabolizers may potentially experience adverse drug events, even without taking a second drug that acts as an inhibitor. In this article, I’ll use CYP3A4 as an example, but this same concept can also be applied to other cytochrome p450 genes.

Every dollar you invest helps us build our company with the goal to grow quickly—but responsibly. 

We are building a company together with you and are focused on innovation and a better future for everyone. Your contribution will help us scale and help our goal to become a leader in the US market.